Series A · Medtech & Devices · Athens, Greece · Founded 2014 · 17–21 employees
RTsafe develops FDA-cleared, patient-specific anatomically-exact models of human head and brain tissue using 3D printing technology for radiation oncology quality assurance. Their PseudoPatient technology allows radiotherapy clinics to simulate radiation therapy for each patient in a risk-free environment before actual treatment, maximizing cancer patient safety and treatment effectiveness. The company won an R&D 100 Award in 2019, recognizing their product as one of the 100 most significant high-tech products worldwide. RTsafe has secured commercial agreements with leading radiation therapy companies like Elekta A.B. and serves prestigious medical institutions including Mayo Clinic, UCLA, and UT Health San Antonio MD Anderson.
No open roles listed right now.